Pancreatic insulin content also showed a marked trend toward higher levels in Leucettinib-92-treated GK rats compared to untreated animals ( Figure 4 E).
← all excerpts
DYRK1A inhibition restores pancreatic functions and improves glucose metabolism in a preclinical model of type 2 diabetes.
1
—
—